As shown in Figure 4, the tumor-bearing mice in the model group had higher levels of TGF-β1 (Figure 4(a)) and IL-10 (Figure 4(b)) in serum than those in the control group (P < 0.01), while LBP-treated mice had lower levels of such cytokines in serum when compared with model mice (P < 0.05 and P < 0.01, resp). The gene discussed is IL10; the disease is neoplasm.